Genetic prediction of common complex disorders assessed by next generation sequencing and genome wide analysis

Italian Journal of Public Health

Volumn 9, Issue 4, 2012, Pages

  Dallapiccola, Bruno ^a   Mingarelli, Rita ^a   Boccia, Stefania ^b,c  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Common complex disorders; Direct to consumer genetic testing; Genetic counseling; Genetic prediction; Genetics; Genome wide association studies; Heritability

Indexed keywords

EID: 84871585120     PISSN: 17237815     EISSN: None     Source Type: Journal    
DOI: 10.2427/8691     Document Type: Article

References (38)

1. Reich DE, Lander ES. On the allelic spectrum of human diseases. Trends Genet 2001; 17:502-510
2. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229
3. Spencer CC, Su Z, Donnelly P, Marchini J. Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip. PLoS Genet 2009; 5: e1000477
4. Hindroff IA, Junkins HA, Manolio TA. NHGRI catalog of published genome-wide association studies. http://www.genome.gov/gwastudies. [Accessed May 26, 2012]
5. Boccia S, De Feo E, Gallì P, et al. A systematic review evaluating the methodological aspects of meta-analyses of genetic association studies in cancer research. Eur J Epidemiol 2010; 25: 765-775
6. Web page HuGE Navigator. http://hugenavigator.net/HuGENavigator/home.do. [Accessed May 26, 2012]
7. Maller J, George S, Purcell S, et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 2006; 38: 1055-1059
8. Raychaudhuri S, Iartchouk O, Chin K, et al. A rare penetrant mutation in CFH confers high risk of agerelated macular degeneration. Nat Genet. 2011; 43: 1232-1236
9. Franke A, McGovern DP, Barrett JC, et al. Genomewide meta-analysis increases to 71 the number of confirmed Crohn disease susceptibility loci. Nat Genet 2010; 42: 1118-1125
10. Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci indentified through largescale association analysis. Nat Genet 2010; 42: 579-589
11. Barrett JC, Clayton DG, Concannon P, et al. Genomewide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41: 703-707
12. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010; 466: 707-713
13. Uda M, Galanello R, Sanna S, et al. Genome-wide association study shows BCL11A associated with persistent hemoglobin and amelioration of the phenotype of β-thalassemia. Proc Natl Acad Sci USA 2008; 105: 1620-1625
14. Lango Allen H, Estrada K, Lettre G, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010; 467: 832-8
15. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010; 363: 166-476
16. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106: 9362-9367
17. Goldstein DB. Common genetic variation on human traits. N Engl J Med 2009; 360: 1696-1698
18. Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common diseases. J Clin Invest 2008; 118: 1590-1605
19. Krueger GG, Langley RG, Leonardi C, et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 2007; 356: 580-592
20. Guttmacher AE, McGuire AL, Ponder B, Stefansson K. Personalized genomic information: preparing for the future of genetic medicine. Nat Rev Genet 2010; 11: 161-165
21. Scheuner MT, Whitworth WC, McGruder H, et al. Expanding the definition of positive family history for early-onset coronary heart disease. Genet Med 2006; 8: 491-501
22. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ; GRIPS Group. Strengthening the reporting of Genetic Risk Prediction Studies: the GRIPS statement. IJPH, 2012: 9 (2):115-121
23. Ormond KE, Wheeler MT, Hudgins L, et al. Challenges in the clinical application of wholegenome sequencing. Lancet 2010; 375: 1749-1751
24. Lender ES. Initial impact of the sequencing of the human genome. Nature 2011; 470: 187-197
25. Janssens AC, Gwinn M, Bradley LA, et al. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet 2008; 82: 593-599
26. United Stated Government Accountability Office. Direct to consumer genetic test. Misleading test results are further complicated by deceptive marketing and other questionable practices. GAO- 10-847T, July 22, 2010 (www.gao.gov/new.items/d10847t.pdf)
27. European Society of Human Genetics: Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes. Eur J Hum Genet 2010, 1-3
28. Human Genetics Commission. Common framework of principles for direct-to-consumer genetic testing, 2010. Report available at www.hgc.gov.uk [Accessed May 26, 2012]
29. Direct-to-consumer genetic testing for health-related purposes in the European Union: the view from EASAC and FEAM [http://www.easac.eu/home/reports-and-statements/detail-view/article/direct-to-co.html,accessed Oct 2012]
30. Fears R, Ter Meulen V. The perspective from EASAC and FEAM on direct-to-consumer genetic testing for health-related purposes. Eur J Hum Genet. 2012; doi: 10.1038/ejhg.2012.238
31. Burke W, Burton H, Hall AE, Karmali M, Khoury MJ, Knoppers B, Meslin EM, Stanley F, Wright CF, Zimmern RL; Ickworth Group. Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and "personalized" medicine? Genet Med. 2010; 12 (12): 785-91
32. Armstrong K. Can genomics bend the cost curve? JAMA 2012; 307 (10): 1031-2
33. Web page Unitedhealth group. http://www.unitedhealthgroup.com/hrm/UNH_WorkingPaper7.pdf. [Accessed May 26, 2012]
34. Sørensen K, Brand H. Health literacy: the essential catalyst for the responsible and effective translation of genome-based information for the benefit of population health. Public Health Genomics 2011; 14 (4-5): 195-200
35. Web page Centro nazionale per la prevenzione e il controllo delle malattie (CCM). http://www.ccm-network.it/documenti_Ccm/programmi_e_progetti/2011/progetti-esecutivi-approvati.pdf. [Accessed March 1, 2012]
36. Web page Centro nazionale per la prevenzione e il controllo delle malattie (CCM). I contenuti del Pnp 2010-2012. February 7, 2011, http://www.ccm-network.it/Pnp_2010-2012_contenuti. [Accessed March 1, 2012]
37. Boccia S, Simone B, Gualano MR, et al. La Genomica in Sanità Pubblica. Sintesi delle evidenze e delle conoscenze disponibili sull'utilizzo della genomica ai fini della prevenzione. IJPH 2012; 9 (1), Suppl. 1
38. Ashley EA, Butte A, Wheeler MT, et al. Clinical assessment incorporating a personal genome. Lancet 2010; 375: 1525-35